212 related articles for article (PubMed ID: 27109862)
21. Systemic Amyloidosis Due to Clonal Plasma Cell Diseases.
Bianchi G; Kumar S
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1009-1026. PubMed ID: 33099420
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of clonal bone marrow CD19+ B cells: use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis.
Manske MK; Zuckerman NS; Timm MM; Maiden S; Edelman H; Shahaf G; Barak M; Dispenzieri A; Gertz MA; Mehr R; Abraham RS
Clin Immunol; 2006 Jul; 120(1):106-20. PubMed ID: 16515886
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of plasma cells in bone marrow and serum free light chains in primary systemic AL amyloidosis.
Yoshida T; Matsuda M; Katoh N; Tazawa K; Shimojima Y; Gono T; Ishii W; Nakazawa Y; Sakashita K; Koike K; Yamada T; Ikeda S
Intern Med; 2008; 47(20):1783-90. PubMed ID: 18854629
[TBL] [Abstract][Full Text] [Related]
24. Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.
Dasari S; Theis JD; Vrana JA; Meureta OM; Quint PS; Muppa P; Zenka RM; Tschumper RC; Jelinek DF; Davila JI; Sarangi V; Kurtin PJ; Dogan A
J Proteome Res; 2015 Apr; 14(4):1957-67. PubMed ID: 25734799
[TBL] [Abstract][Full Text] [Related]
25. Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.
Abraham RS; Manske MK; Zuckerman NS; Sohni A; Edelman H; Shahaf G; Timm MM; Dispenzieri A; Gertz MA; Mehr R
J Clin Immunol; 2007 Jan; 27(1):69-87. PubMed ID: 17192818
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic analysis of plasma cells in bone marrow using flow cytometry in AL amyloidosis.
Matsuda M; Gono T; Shimojima Y; Hoshii Y; Ikeda S
Amyloid; 2003 Jun; 10(2):110-6. PubMed ID: 12964418
[TBL] [Abstract][Full Text] [Related]
27. CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy.
Zhou P; Comenzo RL; Olshen AB; Bonvini E; Koenig S; Maslak PG; Fleisher M; Hoffman J; Jhanwar S; Young JW; Nimer SD; Boruchov AM
Blood; 2008 Apr; 111(7):3403-6. PubMed ID: 18216299
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in the management of AL Amyloidosis.
Kastritis E; Dimopoulos MA
Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
[TBL] [Abstract][Full Text] [Related]
29. Correlation between serum levels of free light chain and phenotype of plasma cells in bone marrow in primary AL amyloidosis.
Shimojima Y; Matsuda M; Gono T; Ishii W; Fushimi T; Hoshii Y; Yamada T; Ikeda S
Amyloid; 2005 Mar; 12(1):33-40. PubMed ID: 16076609
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotype of neoplastic plasma cells in AL amyloidosis.
Deshmukh M; Elderfield K; Rahemtulla A; Naresh KN
J Clin Pathol; 2009 Aug; 62(8):724-30. PubMed ID: 19638544
[TBL] [Abstract][Full Text] [Related]
31. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases.
Swan N; Skinner M; O'Hara CJ
Am J Clin Pathol; 2003 Oct; 120(4):610-6. PubMed ID: 14560572
[TBL] [Abstract][Full Text] [Related]
33. Localized Immunoglobulin Light Chain Amyloid of the Conjunctiva Confirmed by Mass Spectrometry Without Evidence of Systemic Disease.
Hamill EB; Thyparampil PJ; Yen MT
Ophthalmic Plast Reconstr Surg; 2017; 33(5):e108-e110. PubMed ID: 27861403
[TBL] [Abstract][Full Text] [Related]
34. New developments in diagnosis, risk assessment and management in systemic amyloidosis.
Vaxman I; Dispenzieri A; Muchtar E; Gertz M
Blood Rev; 2020 Mar; 40():100636. PubMed ID: 31706583
[TBL] [Abstract][Full Text] [Related]
35. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
van Velzen JF; van den Blink D; Bloem AC
Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
[TBL] [Abstract][Full Text] [Related]
36. Future directions in the clinical management of amyloid light-chain amyloidosis.
Haider S; Ahmad N; Anaissie E; Driscoll JJ
Leuk Lymphoma; 2014 Oct; 55(10):2241-51. PubMed ID: 24359238
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of systemic light chain AL amyloidosis.
Bhutani D; Lentzsch S
Pharmacol Ther; 2020 Oct; 214():107612. PubMed ID: 32562825
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis.
von Keudell G; Sanchorawala V; O'Hara C; C Seldin D; Sloan JM
Amyloid; 2014 Jun; 21(2):124-7. PubMed ID: 24471777
[TBL] [Abstract][Full Text] [Related]
39. [The clinical significance of serum free light chain in primary systemic amyloidosis].
Zhai YP; Song P; Li F; Liu HN; Yu YP; Zhou XG; Shi P; An ZM; Zhou X; Zhang CN
Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):404-7. PubMed ID: 21624224
[TBL] [Abstract][Full Text] [Related]
40. Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
Kimura K; Tsukamoto S; Miyazaki K; Kawajiri-Manako C; Ishii A; Rahmutulla B; Fukuyo M; Oshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Iseki T; Matsusaka K; Sanada M; Yokote K; Kaneda A; Ishida T; Suzuki K; Nakaseko C; Sakaida E
Exp Hematol; 2021 Sep; 101-102():34-41.e4. PubMed ID: 34411686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]